Searched over 200M research papers
9 papers analyzed
These studies suggest that iron saturation is a critical factor in diagnosing and managing iron deficiency, anemia, and related conditions, with various methods and treatments available to improve iron status and health outcomes.
20 papers analyzed
Establishing accurate reference intervals for iron markers in children is crucial for diagnosing iron deficiency. A study involving 1,355 healthy children aged 6-12 years established reference intervals for ferritin, iron, transferrin, and transferrin saturation. The study found that 8.2% of the children were iron deficient, a higher prevalence than in other populations.
In hemodialysis patients with high ferritin and low transferrin saturation (TSAT), intravenous ferric gluconate has been shown to be effective. The DRIVE study demonstrated that intravenous iron significantly increased hemoglobin levels and TSAT compared to no iron treatment. This suggests that intravenous iron is beneficial for anemic dialysis patients with specific iron status markers.
A Mendelian randomization study explored the effects of genetically determined iron status on health outcomes. Higher iron levels were associated with a reduced risk of iron deficiency anemia and hypercholesterolemia but increased the risk of skin infections. This highlights the complex role of iron in various physiological processes and health conditions.
The efficacy of different oral iron preparations in patients receiving recombinant human erythropoietin was evaluated. The study found variability in maintaining adequate iron levels, with ferrous fumarate (Tabron) showing the highest percentage of transferrin saturation above 20%. This indicates that the choice of iron preparation can significantly impact treatment outcomes.
Using transferrin saturation in addition to ferritin improves the diagnosis of iron deficiency, especially in patients with chronic inflammatory diseases. This approach helps in better identifying iron deficiency, which is often under-diagnosed due to the lack of standardized diagnostic criteria.
In hemodialysis patients, high serum ferritin combined with low iron saturation is often associated with inflammation rather than iron status. This suggests that inflammation can confound the assessment of iron status, complicating the management of anemia in these patients.
Various methods, including Chromametry, Differential Scanning Calorimetry (DSC), and Circular Dichroism (CD) spectropolarimetry, have been evaluated for determining iron saturation in lactoferrin. These methods provide reliable data for estimating iron saturation levels, which is important for understanding the functional properties of lactoferrin.
The increasing prevalence of comorbidities in anemic patients with chronic kidney disease has made traditional markers like serum ferritin and transferrin saturation less reliable. Newer markers, such as reticulocyte hemoglobin content and soluble transferrin receptor, show promise in providing a more accurate assessment of iron status.
Total iron-binding capacity (TIBC) can be calculated from serum transferrin concentration or serum iron concentration and unsaturated iron-binding capacity. This method is useful for diagnosing iron-deficiency anemia and other conditions, providing a reliable measure of the body's iron-binding capacity.
Recent research highlights the complexity of assessing and managing iron status, particularly in specific populations like children and hemodialysis patients. Advances in diagnostic criteria and treatment options, including the use of genetic data and newer biomarkers, offer promising avenues for improving iron deficiency diagnosis and treatment.
Most relevant research papers on this topic